Don’t miss the latest developments in business and finance.

WHO-led COVAX vaccine scheme agrees new supply deal with Serum Institute

Serum Institute will supply 1.1 billion doses of Covid-19 vaccines developed by AstraZeneca and Novavax to the COVAX vaccine scheme

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma
Representational image of Covaxin
Reuters GENEVA/LONDON
1 min read Last Updated : Feb 03 2021 | 7:37 PM IST

India's Serum Institute will supply 1.1 billion doses of COVID-19 vaccines developed by AstraZeneca and Novavax to the COVAX vaccine scheme as part of a new long-term deal, head of the U.N. Children's Fund said on Wednesday.

UNICEF chief Henrietta Fore said the shots would be delivered over a number of years at the cost of about $3 per dose for low- and middle-income countries.

They would be produced by Serum under a technology transfer agreement, she said in a briefing.

The COVAX facility is co-led by GAVI, the World Health Organization, the Coalition for Epidemic Preparedness Innovations and UNICEF.

Also Read

Topics :CoronavirusCoronavirus VaccineSerum Institute of India

First Published: Feb 03 2021 | 7:29 PM IST

Next Story